Earnings History Data for Candel Therapeutics, Inc. (CADL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Candel Therapeutics, Inc.
Candel Therapeutics Inc. is a late clinical stage biopharmaceutical company. It involved in developing novel oncolytic viral immunotherapies. The company's product pipeline includes CAN-2409 and CAN-3110. Candel Therapeutics Inc. is based in NEEDHAM, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-03-2024 | PM | CADL | Candel Therapeutics | 43.00 | -0.38 | -0.16 | 0.00 | Candel Therapeutics GAAP EPS of -$0.38 [3/28/2024 9:00 AM] |
1.57 | 0.03 (1.95%) |
0.0 | 0.0 (0.00%) |
0.66 - 1.95 | 21,872 | 40,000 | 0 | ||
| 10-08-2023 | PM | CADL | Candel Therapeutics | 32.00 | -0.33 | -0.23 | 0.00 | Candel Therapeutics GAAP EPS of -$0.33 [8/10/2023 10:08 AM] |
1.06 | -0.04 (-3.64%) |
1.03 | -0.07 (-6.36%) |
0.98 - 4.25 | 3,163 | 20,000 | 1,560 | ||
| 30-03-2023 | PM | CADL | Candel Therapeutics | 40.00 | -0.18 | -0.16 | 0.00 | Candel Therapeutics GAAP EPS of -$0.18 [3/30/2023 9:46 AM] |
1.38 | -0.03 (-1.99%) |
0.0 | 0.0 (0.00%) |
1.30 - 5.75 | 1,098 | 20,000 | 0 | ||
| 10-11-2022 | PM | CADL | Candel Therapeutics | 45.00 | -0.30 | -0.53 | 0.00 | Candel Therapeutics GAAP EPS of -$0.30 beats by $0.10 [11/10/2022 9:30 AM] |
1.69 | 0.19 (12.67%) |
0.0 | 0.0 (0.00%) |
1.47 - 11.23 | 33,656 | 50,000 | 0 | ||
| 05-08-2022 | PM | CADL | Candel Therapeutics | 95.00 | -0.14 | -0.54 | 0.00 | 3.50 | 0.05 (1.45%) |
3.45 | 0.0 (0.00%) |
2.81 - 14.78 | 11,276 | 0 | 210 | |||
| 12-05-2022 | PM | CADL | Candel Therapeutics | 110.00 | -0.03 | -0.49 | 0.00 | Candel Therapeutics GAAP EPS of -$0.03 [5/12/2022 8:32 AM] |
3.80 | 0.13 (3.54%) |
0.0 | 0.0 (0.00%) |
3.33 - 14.78 | 32,148 | 20,000 | 0 | ||
| 12-11-2021 | PM | CADL | Candel Therapeutics | 315.00 | -0.34 | -0.27 | 0.00 | Candel Therapeutics reports Q3 results [11/12/2021 12:24 PM] |
11.03 | 0.09 (0.78%) |
0.0 | 0.0 (0.00%) |
5.51 - 14.78 | 1,980 | 30,000 | 0 | ||
|
||||||||||||||||||